Back
Cytokinetics Quote, Financials, Valuation and Earnings
Sponsored
CYTK
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
56
CYTK
Cytokinetics
Last Price:
55.63
Seasonality Move:
-5.12%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Cytokinetics Price Quote
$55.63
-0.31 (-0.55%)
(Updated: September 19, 2024 at 6:55 PM ET)
Cytokinetics Key Stats
Buy
56
Cytokinetics (CYTK)
is a Buy
Day range:
$53.88 - $57.76
52-week range:
$25.98 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,813.20
P/B ratio:
60.63%
Volume:
1.4M
Avg. volume:
1.2M
1-year change:
65.16%
Market cap:
$6.6B
Revenue:
$7.5M
EPS:
$-5.37
How Much Does Cytokinetics Make?
-
How Much Are Cytokinetics's Sales Annually?
CYTK Revenues are $7.5M -
How Much Profit Does Cytokinetics's Make A Year?
CYTK net income is -$526.2M
Is Cytokinetics Growing As A Company?
-
What Is Cytokinetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.71% -
What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cytokinetics Stock Price Performance
-
Did Cytokinetics Stock Go Up Last Month?
Cytokinetics share price went down by -0.99% last month -
Did CYTK's Share Price Rise Over The Last Year?
CYTK share price rose by 65.16% over the past 1 year
What Is Cytokinetics 52-Week High & Low?
-
What Is Cytokinetics’s 52-Week High Share Price?
Cytokinetics has traded as high as $110.25 over the past 52 weeks -
What Is Cytokinetics’s 52-Week Low Share Price?
Cytokinetics has traded as low as $25.98 over the past 52 weeks
Cytokinetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cytokinetics?
-
How Much Debt Does Cytokinetics Have?
Total long term debt quarterly is $655M -
How Much Cash Does Cytokinetics Have?
Cash and short term investments quarterly total is $1.1B -
What Is Cytokinetics’s Book Value Per Share?
Book value per share is 0.92
Is Cytokinetics Cash Flow Positive?
-
What Is CYTK Cash Flow From Operations?
Cash flow from operations (TTM) is -$399.1M -
What Is Cytokinetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.1B -
What Is Cytokinetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$627.3M
Cytokinetics Return On Invested Capital
-
Is Management Doing A Good Job?
CYTK return on invested capital is -163.9% -
What Is Cytokinetics Return On Assets?
ROA measures how assets are converting to revenues and is -58.3% -
What Is CYTK Return On Equity?
ROE is a measure of profitability and is 0%
Cytokinetics Earnings Date & Stock Price
-
What Is Cytokinetics's Stock Price Today?
A single share of CYTK can be purchased today for 55.94 -
What Is Cytokinetics’s Stock Symbol?
Cytokinetics trades on the nasdaq under the ticker symbol: CYTK -
When Is Cytokinetics’s Next Earnings Date?
The next quarterly earnings date for Cytokinetics is scheduled on November 1, 2024 -
When Is CYTK's next ex-dividend date?
Cytokinetics's next ex-dividend date is September 20, 2024 -
How To Buy Cytokinetics Stock?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cytokinetics Competitors
-
Who Are Cytokinetics's Competitors?
Below is a list of companies who compete with Cytokinetics or are related in some way:
Cytokinetics Dividend Yield
-
What Is CYTK Dividend Yield?
Cytokinetics’s dividend yield currently is 0% -
What Is Cytokinetics’s Payout Ratio?
Cytokinetics’s payout ratio is 0% -
When Did Cytokinetics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Cytokinetics’s Dividend Per Share?
Cytokinetics pays a dividend of $0.00 per share
Cytokinetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -44.38% |
Revenue: | -71.28% | -98.81% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 81.29 |
Upside from Last Price: | 45.32% |